[1]
“Cost‑effectiveness analysis of hexaminolevulinate (Hexvix®) guided cystoscopy in Non‑Muscle Invasive Bladder Cancer patients (NMIBC) in Italy”, FE, vol. 15, no. 3, Sep. 2014, doi: 10.7175/fe.v15i3.944.